BACKGROUND: The cannabis plant contains several cannabinoids, and many terpenoids that give cannabis its distinctive flavoring and aroma. Î(9)-Tetrahydrocannabinol (Î(9)-THC) is the plant's primary psychoactive constituent. Given the abuse liability of Î(9)-THC, assessment of the psychoactive effects of minor cannabinoids and other plant constituents is important, especially for compounds that may be used medicinally. This study sought to evaluate select minor cannabinoids and terpenes for Î(9)-THC-like psychoactivity in mouse Î(9)-THC drug discrimination and determine their binding affinities at CB(1) and CB(2) receptors. METHODS: Î(9)-THC, cannabidiol (CBD), cannabinol (CBN), cannabichromene (CBC), cannabichromenevarin (CBCV), Î(8)-tetrahydrocannabinol (Î(8)-THC), (6aR,9R)-Î(10)-tetrahydrocannabinol [(6aR,9R)-Î(10)-THC], Î(9)-tetrahydrocannabinol varin (THCV), β-caryophyllene (BC), and β-caryophyllene oxide (BCO) were examined. RESULTS: All minor cannabinoids showed measurable cannabinoid 1 (CB(1)) and cannabinoid 2 (CB(2)) receptor binding, with CBC, CBCV, and CBD, showing the weakest CB(1) receptor binding affinity. BC and BCO exhibited negligible affinity for both CB(1) and CB(2) receptors. In drug discrimination, only Î(8)-THC fully substituted for Î(9)-THC, while CBN and (6aR,9R)-Î(10)-THC partially substituted for Î(9)-THC. THCV and BCO did not alter the discriminative stimulus effects of Î(9)-THC. CONCLUSION: In summary, only some of myriad cannabinoids and other chemicals found in the cannabis plant bind potently to the identified cannabinoid receptors. Further, only four of the compounds tested herein [Î(9)-THC, Î(8)-THC, (6aR,9R)-Î(10)-THC, and CBN] produced Î(9)-THC-like discriminative stimulus effects, suggesting they may possess cannabimimetic subjective effects. Given that the medicinal properties of phytocannabinoids and terpenoids are being investigated scientifically, delineation of their potential adverse effects, including their ability to produce Î(9)-THC-like intoxication, is crucial.
Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.
阅读:3
作者:Wiley Jenny L, Marusich Julie A, Blough Bruce E, Namjoshi Ojas, Brackeen Marcus, Akinfiresoye Luli R, Walker Teneille D, Prioleau Cassandra, Barrus Daniel G, Gamage Thomas F
| 期刊: | Progress in Neuro-Psychopharmacology & Biological Psychiatry | 影响因子: | 3.900 |
| 时间: | 2024 | 起止号: | 2024 Jun 8; 132:110984 |
| doi: | 10.1016/j.pnpbp.2024.110984 | ||
特别声明
1、本文转载旨在传播信息,不代表本网站观点,亦不对其内容的真实性承担责任。
2、其他媒体、网站或个人若从本网站转载使用,必须保留本网站注明的“来源”,并自行承担包括版权在内的相关法律责任。
3、如作者不希望本文被转载,或需洽谈转载稿费等事宜,请及时与本网站联系。
4、此外,如需投稿,也可通过邮箱info@biocloudy.com与我们取得联系。
